175 related articles for article (PubMed ID: 10573111)
1. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.
Hansen RK; Parra I; Lemieux P; Oesterreich S; Hilsenbeck SG; Fuqua SA
Breast Cancer Res Treat; 1999 Jul; 56(2):187-96. PubMed ID: 10573111
[TBL] [Abstract][Full Text] [Related]
2. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
Harris LN; Yang L; Tang C; Yang D; Lupu R
Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells.
Zhang D; Putti TC
Exp Cell Res; 2010 Dec; 316(20):3522-31. PubMed ID: 20833165
[TBL] [Abstract][Full Text] [Related]
5. Altered topoisomerase IIalpha and multidrug resistance-associated protein levels during drug selection: adaptations to increasing drug pressure.
Matsumoto Y; Takano H; Nagao S; Fojo T
Jpn J Cancer Res; 2001 Sep; 92(9):968-74. PubMed ID: 11572765
[TBL] [Abstract][Full Text] [Related]
6. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
[TBL] [Abstract][Full Text] [Related]
7. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
[TBL] [Abstract][Full Text] [Related]
8. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES
Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and gamma rays increase the level of DNA topoisomerase IIalpha in nuclei of normal and xeroderma pigmentosum fibroblasts.
Thielmann HW; Popanda O
J Cancer Res Clin Oncol; 1998; 124(7):355-66. PubMed ID: 9719498
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibition circumvents solid tumor resistance to topoisomerase II-directed drugs.
Ogiso Y; Tomida A; Lei S; Omura S; Tsuruo T
Cancer Res; 2000 May; 60(9):2429-34. PubMed ID: 10811120
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HER2, p53, bcl-2, topoisomerase II-alpha, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes.
Cardoso F; Di Leo A; Larsimont D; Gancberg D; Rouas G; Dolci S; Ferreira F; Paesmans M; Piccart M
Ann Oncol; 2001 May; 12(5):615-20. PubMed ID: 11432618
[TBL] [Abstract][Full Text] [Related]
12. Regulation of BAX and BCL-2 expression in breast cancer cells by chemotherapy.
Gibson LF; Fortney J; Magro G; Ericson SG; Lynch JP; Landreth KS
Breast Cancer Res Treat; 1999 May; 55(2):107-17. PubMed ID: 10481938
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
Järvinen TA; Holli K; Kuukasjärvi T; Isola JJ
Br J Cancer; 1998 Jun; 77(12):2267-73. PubMed ID: 9649144
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of the catalytic inhibition of human topoisomerase IIα by salicylate analogs and salicylate-based drugs.
Bau JT; Kurz EU
Biochem Pharmacol; 2014 Jun; 89(4):464-76. PubMed ID: 24695359
[TBL] [Abstract][Full Text] [Related]
15. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy.
Díaz-Chávez J; Fonseca-Sánchez MA; Arechaga-Ocampo E; Flores-Pérez A; Palacios-Rodríguez Y; Domínguez-Gómez G; Marchat LA; Fuentes-Mera L; Mendoza-Hernández G; Gariglio P; López-Camarillo C
PLoS One; 2013; 8(5):e64378. PubMed ID: 23724044
[TBL] [Abstract][Full Text] [Related]
16. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.
Oesterreich S; Weng CN; Qiu M; Hilsenbeck SG; Osborne CK; Fuqua SA
Cancer Res; 1993 Oct; 53(19):4443-8. PubMed ID: 8402609
[TBL] [Abstract][Full Text] [Related]
17. Introduction of gadd153 gene into gastric cancer cells can modulate sensitivity to anticancer agents in association with apoptosis.
Kim R; Ohi Y; Inoue H; Aogi K; Toge T
Anticancer Res; 1999; 19(3A):1779-83. PubMed ID: 10470115
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
19. Inconstant association between 27-kDa heat-shock protein (Hsp27) content and doxorubicin resistance in human colon cancer cells. The doxorubicin-protecting effect of Hsp27.
Garrido C; Mehlen P; Fromentin A; Hammann A; Assem M; Arrigo AP; Chauffert B
Eur J Biochem; 1996 May; 237(3):653-9. PubMed ID: 8647109
[TBL] [Abstract][Full Text] [Related]
20. Response of human breast cancer cells to heat shock and chemotherapeutic drugs.
Ciocca DR; Fuqua SA; Lock-Lim S; Toft DO; Welch WJ; McGuire WL
Cancer Res; 1992 Jul; 52(13):3648-54. PubMed ID: 1617638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
